In summary, the key outcomes include hyperglycemia, hyperinsulinemia, insulin resistance, dyslipidemia, increased inflammation and oxidative stress, and structural changes and changes to the expression of proteins related to insulin signaling and carbohydrate and lipid metabolism in various tissues. The gene discussed is INS; the disease is metabolic syndrome.